ENT surgeons commonly use endoscopic approaches to remove brain tumors through the nose by making a window through the blood-brain barrier to access the brain.
and a tumor, says Ali Salanti, who headed up one of the teams responsible for the discovery. he placenta is an organ,
In a manner of speaking, tumors do much the same; they grow aggressively in a relatively foreign environment. hile studying the placenta,
Those with mutations in polycystic kidney disease genes formed balloon-like, fluid-filled sacks, called cysts, from kidney tubules.
#Drug combo shows promise for skin cancer n transitnew melanoma research finds a combination therapy is highly effective at treating patients with skin metastases.
t unclear if the recently developed targeted melanoma therapies that have revolutionized management of patients with internal melanoma metastases are useful in patients with metastatic disease limited of the skin,
Although intralesional IL-2 has recently been included in the US National Comprehensive Cancer Network guidelines for management of melanoma metastases of the skin
About 10 percent of patients with advanced melanoma develop what are called cutaneous metastases, often located n-transitto the patientslymph nodes.
or stage IV melanoma who had history of treatment with IL-2 therapy combined with imiquimod and a topical retinoid.
and seven were alive at the conclusion of the study without melanoma recurrence. The remaining five patients died from unrelated causes. he favorable outcomes in these patients are encouraging
The scientists settled on just three proteins after conducting proteomic analyses of 488 urine samples92 from patients with pancreatic ductal adenocarcinoma (PDAC
The panel performance was described August 3 in the journal Clinical Cancer Research, in an article entitled, dentification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma. hen comparing
the survival rate for patients with very small tumors can increase up to 60%.%It is hoped that with early detection,
and carry them to tumors expressing the specific carbohydrate residue.""Based on our clinical data, we helped validate that this could be applied to melanoma
and lung cancers,"explained co-author Nhan Tran, Ph d.,associate professor in TGEN's Cancer and Cell biology Division."
and is expressed also in lung cancer and melanoma.""The findings from this study were published recently in Cancer cell through an article entitled argeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein."
we immediately saw its potential to deliver cancer drugs in a precise, controlled way to tumors."
or conjugated to hemiasterlin (a microtubule inhibitor) and saw strong inhibition of tumor cell growth and metastasis in vivo."
#MIT's acoustic tumor cell sorting method is now up to 20 times faster A team of researchers from MIT,
The team also tested the improved method on blood samples obtained from three breast cancer patients, isolating one, eight and 59 tumor cells.
for both basic research into the complex topic of circulating tumor cells and for clinical assessment of different types of cancer,"said Carnegie mellon president Subra Suresh.
But now, researchers have developed genetically modified salmonella that turns toxic only after it enters a tumor.
This strain has been demonstrated to colonize tumors and attack the cancer cells. It was the group's thinking that altering part of the bacteria's outer membrane called the lipopolysaccharide structure (LPS) could serve to improve its safety.
They then tested variants of the newly modified Salmonella strains both in the lab with human cancer cells and in mice with tumors.
and shrinking the tumors when injected into the mice, without the typical negative impacts on the surrounding healthy cells.
when it arrives at the tumor is attributed to how Salmonella develops in different environments. In regular cells, Salmonella will divide only once or twice each day,
while inside a tumor it divides hourly.""This transition from a benign, invasive Salmonella that doesn't hurt normal cells to the toxic type occurs very rapidly (time wise) in the tumor due to the very rapid growth
and cell division that occurs when Salmonella enters a tumor, "says Dr. Roy Curtiss, one of the study's researchers and Professor of Microbiology at Arizona State university.
Curtiss says that when the technique finds it way into human trials, it will most likely be used in conjunction with chemotherapy and radiation therapy.
including following tumor removal, spinal fusion surgery or fractures. Normally, bone grafts involve using bone from another part of the patient's body,
and then later initiating tumor growth, Dr. Sanaz Memarzadeh, a senior author of the study said.
How We Might Starve Tumors by Cutting off Food supply In their hunger to find ways to cure cancer,
scientists may have found a method to starve tumors to death. Cancer cells must find nutrients to grow.
and their research suggests it may be possible to starve tumors by targeting it. e found that aggressive cancer cells manufacture more PAT4,
while patients that showed higher levels had more trouble fighting tumors and a higher chance of remission.
it will slow tumor growth. Now that theye identified a mechanism that allows tumors to grow
the researchers believe they can find a way to use it as part of a combination treatment that will lead to a higher survival rate for patients.
Those with mutations in polycystic kidney disease genes formed balloon-like, fluid-filled sacks, called cysts, from kidney tubules.
while doctors seek the right chemicals to beat back a tumor. Now, two research teams say they have found ways to speed up the process by allowing doctors to try multiple treatments at once:
The device can be used to inject multiple drugs into tumors that are close to the surface of a person's skin.
First, the needles are loaded with drugs, pressed into the tumor and then withdrawn, with each needle leaving behind a columnlike trail of a drug that spans the full depth of the tumor.
one to three days later, researchers can remove a piece of the tumor and examine the cells to see the effect of each drug
whether it killed the tumor cells, slowed their growth or had no effect. That analysis can tell doctors
the cylinder is designed to be implanted into the tumor, and then diffusion allows the drugs to move from the tubes into the surrounding cancerous tissue.
A biopsy of the tumor is taken a day or two later a doctor removes the cylinder
or water contaminated with its cysts. The ameba passes into the environment via feces and can survive outside the human body for several weeks in this protective cyst form.
E. histolytica infection is endemic in regions with poor sanitation and improving sanitation has been the primary means to stop infections,
or water contaminated with its cysts. The ameba passes into the environment via feces and can survive outside the human body for several weeks in this protective cyst form.
E. histolytica infection is endemic in regions with poor sanitation and improving sanitation has been the primary means to stop infections,
The technology, published in journal Science Translational Medicine, measures the level of circulating tumor DNA (ctdna),
the DNA that has been shed by circulating tumor cells, in plasma isolated from blood. By measuring the level of genetic mutations in the ctdna,
Zev Gartner, Phd, the paper senior author, stated that he hopes to use this technology to study how changes in the structure of mammary glands can cause the destruction of tissue structure that is associated with tumors that metastasize.
but it's very difficult to identify all of the places where a tumor has spread,
some tumors in laboratory animals began to regrow after two weeks. But with the addition of the combinatorial genetic therapy to weaken the cancer cell defenses,
"The tumors exposed to a single dose of a combinatorial therapy were eradicated completely from the mice
#Portable Nanosensors Help Early Diagnosis of Breast cancer Tumors The nanosensor will be able to help the early diagnosis of breast cancer tumors even at very tiny dimensions after the completion of tests
The aim of the research was to facilitate the diagnosis of cancer tumors, including breast cancer, without the need for advanced clinical devices.
and simulated in this research for the early and easy diagnosis of breast tumors. The nanosensor consists of plasmonic nanoparticles that are placed at regular distance from each other.
the sensor is very sensitive to changes in electromagnetic fields that are dispersed with different tissues (normal and tumor.
The throughputs of waves are different through natural and tumor tissues. Therefore, the interaction of tissues with electromagnetic waves created by a similar electrical field ends in different results.
The meaningful signal is a tool for the detection of tumor tissue e
#Pushing the limits of lensless imaging: At the Frontiers in Optics conference researchers will describe a custom-built ultrafast laser that could help image everything from semiconductor chips to cells in real time Using ultrafast beams of extreme ultraviolet light streaming at a 100,000 times a second, researchers
and cure bones damaged due to tumors, cysts or fractures. The use of bone replacement in various forms has increased in recent years.
the researchers found a significant decrease in tumor growth and a doubling of lifespan. The potency was up to an 80-fold increase over linear nucleic acids of the same sequence.
scientists from the Helmholtz Zentrum Mnchen (HMGU) and the Ludwig-Maximilians-Universitt (LMU) in Munich have developed nanocarriers that site-selectively release medicines/drugs at the tumor site in human and mouse lungs.
In the journal, ACS Nano("Protease-Mediated Release of Chemotherapeutics from Mesoporous Silica Nanoparticles to ex Vivo Human and Mouse Lung Tumors"),the scientists reported that this approach led to a significant increase
Tumor tissue in the lung. Image: Sabine van Rijt, CPC/ilbd, Helmholtz Zentrum Mnchen) Nanoparticles are extremely small particles that can be modified for a variety of uses in the medical field.
and other invasive diseases rely on high-resolution imaging to see tumors and other activity deep within the body's tissues.
#Scientists use nanotechnology to visualize potential brain cancer treatments in real time (Nanowerk News) Virginia Tech Carilion Research Institute scientists have developed new imaging techniques to watch dangerous brain tumor
and describes how the research team used nanotechnology to watch tumor stem cells respond to therapy. ee never been able to directly observe the actions of potential cancer treatments this way before,
and grow new tumors. lioblastoma tumors are hard to target, Sheng said. heye aggressive and resistant to therapeutics.
whether we could isolate these types of toxic cells from the other brain tumor cells, while developing new imaging tools at the single-cell level to visualize the course of therapies needed to eradicate these cells,
reducing its accumulation in tumors. Many molecular packaging systems have been developed to deliver the drug while counteracting these effects, with a protein-bound version of the drug called Abraxane currently the leading therapy.
the Duke team doubled tumor exposure to the drug compared to Abraxane while simultaneously reducing its effects on healthy tissue.
This kept mice with tumors alive significantly longer and, in some cases, completely eradicated the tumors.
and accumulate in tumors where they take advantage of a tumor's acidic environment.""The chemical bonds holding the polypeptide cage together are stable in blood,
but dissolve in a tumor's lower ph levels,"said Jayanta Bhattacharyya, senior researcher in Chilkoti's lab and first author on the paper."
"This delivers the drug directly to the tumor and helps prevent it from randomly absorbing into healthy tissue, reducing side effects."
A second group of mice had human prostate tumors growing under their skin. Similarly, while they did not survive past 60 days
the Duke technology showed a higher concentration of paclitaxel in the tumors with more staying power than Abraxane,
such as applying anticancer medications to melanomas or applying growth factors and antibiotics for wound healing, says Jin Di,
however, drugs could be encapsulated in protein cages that accumulate inside of a tumor and dissolve once heated.
steel braces straighten crooked teeth, steel scalpels remove tumors. Most of the goods we consume are delivered by ships
Now, a precise mechanism by which chronic inflammation can lead to cancer has been uncovered by researchers at MIT a development that could lead to improved targets for preventing future tumors.
These include mesothelioma, a type of lung cancer caused by inflammation following chronic exposure to asbestos,
DNA sequencing of a developing gastrointestinal tumor revealed two types of mutation: cytosine (C) bases changing to thymine (T) bases,
or patterns of DNA mutations, associated with cancerous tumors. e believe that in the context of inflammation-induced damage of DNA,
This random pattern of vision loss is in stark contrast to loss from a brain tumor or stroke,
researchers have recently been able to develop precise treatments for cancer by sequencing tumor genomes
and comparing them to the patientsgenomes to better understand what drives the formation and growth of tumors. owever,
in Alzheimer disease, there is no tumor to biopsy, Bredesen said. o how do we get an idea about
The new study shows that this crosstalk is important not only for launching immune responses against tumors,
scientists may be able to develop ways to better control NKTS to attack tumors. The new study also suggests there may be a way to intervene in the pathway to block inflammation.
#Uncovering Clues About Abnormal Embryo Development with Artificial intelligence Melanoma-like cells in tadpoles may mimic variability in human responses to cancer stimuli.
and metastasis of melanoma-like cells in tadpoles as well as work applying artificial intelligence to help explain planarian regeneration.
and developed other melanoma-like characteristics, proliferating uncontrollably and invading the frogsinternal organs. Depending on which protein in the bioelectric pathway was tweaked, only a certain percentage of the frogs developed melanoma,
while the rest remained healthy. here randomness to this process. It doesn have the same result in all animals exposed to precisely the same agent,
Furthermore, the tadpoles that did develop melanoma developed it in every pigment cellach frog was either 100 percent metastatic or completely normal.
proteins of the serotonergic signaling pathway that regulated the melanoma-like cellsbehavior. Then, the team applied artificial intelligence which mimicked evolution to generate a chemical signaling network in a irtual embryothat exhibited the same behavior that the researchers observed in their experiments with real tadpoles.
and targets for tumor prevention and better understanding many other seemingly random decisions made by cells in living organisms.
ENT surgeons commonly use endoscopic approaches to remove brain tumors through the nose by making a window through the blood-brain barrier to access the brain.
The man lost his sternum and pieces of four ribs when doctors removed a large tumor.
The method therefore opens up the prospect of detecting tumors that are less than 1mm in diameter in an early stage of growth before they spread through the body
#Glowing Tumor Paint Shows Surgeons Where To Cut Brain surgery is complicated notoriously. Before surgeons go in to remove a tumor,
they study the size and location of the tumor. But once theye in, they have to rely on their fingers
and eyes to distinguish tumor cells from healthy brain cells. Now researchers have developed a"paint"that can be injected into a patient's veins to make tumor cells glow.
After a number of successful studies in mice and dogs, the paint is now being tested in humans in California.
The paint is made from two chemicals. The first is chlorotoxin a protein derived from scorpion venom,
which targets the chloride receptors on the surface of tumor cells. The protein carries a second,
Researchers injected the tumor paint into the patients'veins and it was successfully able to cross the blood-brain barrier,
The first few test subjects had tumors that were deep in the brain so the surgeons had to remove a piece of the tissue before shining a light on it.
The paint may also be used for other types of tumors in the future. Ideally, doctors wouldn be using surgery at all to eliminate tumors--it still a rudetechnique,
as one researcher said. But while surgery is still a standard treatment, tumor paint could help surgeons be much more precise m
#A 3d-Printed, Battery-Powered Rocket engine Nothing demonstrates engineering prowess and technical knowhow quite like rocket science.
the Food and Drug Administration (FDA) announced that it had approved the drug Imlygic to treat late-stage melanoma on the skin and lymph nodes.
Imlygic was tested in more than 400 patients with metastatic melanoma, which kills about 10,000 people per year in the United states,
So far, virology treatments haven worked as well in cancers in tissues deeper in the bodyhe drug has to be injected directly into the tumor site
British scientists have used also 3d printing to create personalized replica models of cancerous parts of the body to allow doctors to target tumors more precisely y
and whether a tumor is likely to spread to other sites. The findings also open the possibility of new therapies aimed at measuring
and found that Grb2 depletion results in the development of multiple tumors in the vicinity of a primary tumour,
"The scientists demonstrated that blocking PEPCK in cancer cells could slow tumor growth in mice. Alternative fuels for cancer cells The group also found evidence of increased PEPCK levels in tissues from lung-cancer patients."
Assessing just three features of a common kind of testicular cancer-called non-seminomatous germ cell tumor-can identify those at most at risk of relapse even where there is no evidence of tumor spread.
Scientists at The Institute of Cancer Research, London, analyzed 177 tumor samples from patients with stage I non-seminomatous tumors enrolled in clinical trials through the Medical Research Council (MRC
Scientists at The Institute of Cancer Research (ICR found that three different features of the tumors were important indicators of relapse risk:
the levels of a molecule called CXCL12, the percentage of the tumor with an appearance of cancer stem cells and whether or not blood vessels were present in the tumor.
They scored tumors based on these features, and found that combining scores could divide patients up into three different risk groups based on how likely patients were to suffer a relapse of the disease within two years.
Testicular germ cell tumors are the most common solid malignant tumor in young Caucasian men. Patients diagnosed with early-stage disease face a choice between monitoring with treatment
"Patients with stage 1 non-seminomatous germ cell tumors have to make a difficult choice of
called VAR2CSA, could provide the tool for carrying such drugs to tumors. It's somehow fitting that a disease as destructive as malaria might be exploited to treat another dreaded disease like cancer."
"Based on our clinical data, we helped validate that this could be applied to melanoma and lung cancers,"said Dr. Nhan Tran, an Associate professor in Translational Genomics Research Institute (TGEN)' s Cancer and Cell biology Division,
and is expressed also in lung cancer and in melanoma.""Malaria uses VAR2CSA to embed itself in the placenta--hiding itself from the immune system--by binding to oncofetal chondroitin sulfate.
delivering the drug to the tumor.""Scientists have spent decades trying to find biochemical similarities between placenta tissue and cancer,
we immediately saw its potential to deliver cancer drugs in a precise, controlled way to tumors.""
However, until now, the procedure has shown to be unsafe, because of the risk of tumors upon transplantation.
These animals also developed intracerebral tumors. In contrast, animals receiving the treated stem cells showed improvement of Parkinson's symptoms
and survived until the end of the observation period of 12 weeks post-transplant with no tumors detected.
by eliminating the risk of tumor formation, "says the leader of the study Stevens Rehen, Professor at UFRJ and researcher at IDOR.
"When a cancerous tumor begins to develop, the body mobilizes to produce antibodies. Huo's test detects that immune response using gold nanoparticles about 10,000 times smaller than a freckle.
Huo also is researching her technique's effectiveness as a screening tool for other tumors."
#Biologists identify brain tumor weakness The study, led by researchers from the Whitehead Institute and MIT's Koch Institute for Integrative Cancer Research, found that a subset of glioblastoma tumor cells is dependent on a particular enzyme that breaks down the amino acid glycine.
Without this enzyme, toxic metabolic byproducts build up inside the tumor cells, and they die. Blocking this enzyme in glioblastoma cells could offer a new way to combat such tumors,
says Dohoon Kim, a postdoc at the Whitehead Institute and lead author of the study,
which appears in the April 8 online edition of Nature. David Sabatini a professor of biology at MIT and member of the Whitehead Institute, is the paper's senior author.
the most common and most aggressive type of brain tumor found in humans. The researchers found that GLDC,
These regions are often found at the center of tumors, which are inaccessible to blood vessels.
which makes them better suited to survive in the ischemic tumor microenvironment, "Kim says. However, this highly active SHMT2 also produces a glut of glycine,
thus blocking Hur function as a tumor-promoting protein, "said Liang Xu, associate professor of molecular biosciences and corresponding author of the paper.
a critical tumor suppressor, shuts off growth signals Today, scientists at Cold Spring Harbor Laboratory (CSHL) publish new evidence explaining precisely how the protein encoded by PTEN (called PTEN) works--specifically,
And in view of PTEN's critical role as a tumor suppressor, it's also important that the process we uncovered is controlled a one,
as well as physicians from the Rambam, Carmel and Hadassah Medical centers, who are studying tumors and their treatment. kpc1 an important and vital pathway in the life of the cell,
It is involved in tumors of various organs (prostate, breast, lung, head and neck, large intestine, brain, etc.
which are vital to tumor growth; and increased resistance of cancerous cells to irradiation and chemotherapy.
The current research was conducted on models of human tumors grown in mice as well as on samples of human tumors,
and a strong connection was discovered between the suppression of malignancy and the level of the two proteins,
and/or p50 in the tissue can protect it from cancerous tumors. Professor Ciechanover, who is also the president of the Israel Cancer Society,
and gain a solid understanding of the mechanisms behind the suppression of the tumors. The development of a drug based on this discovery is a possibility,
"It could also be a potential biomarker to discriminate between fast and slow growing tumors."
However, in prostate cancer cells, Runx2 triggered genes that fuel tumor growth and metastasis."It's unusual that a protein
and found that tumor growth was reduced. Franceschi's lab also collaborated with researchers in Italy to analyze tissue samples from 129 patients with prostate cancer.
low-cost molecular tumor diagnosis A device developed by Massachusetts General Hospital investigators may bring rapid,
accurate molecular diagnosis of tumors and other diseases to locations lacking the latest medical technology.
and the results rapidly returned to the point of Care for molecular analysis of tumors, a sample of blood or tissue is labeled with microbeads that bind to known cancer-related molecules
A pilot test of the system with cancer cell lines detected the presence of tumor proteins with an accuracy matching that of the current gold standard for molecular profiling,
The discovery point towards the possibility of identifying aggressive melanomas at an earlier stage than is currently possible,
Pigment Cell & Melanoma Research. May be possible to predict disease progression It is the first time that the protein megalin,
and relapse or not from a malignant melanoma.""It is a new and interesting marker that no one has thought of before.
Even though we currently see considerable progress and success from novel treatment strategies for patients with metastatic melanoma,
#Immunotherapy combination promising for untreated patients with advanced melanoma The combination of two immunotherapies for first-line treatment of advanced melanoma induces better responses
Further, the combination was effective in the portion of melanoma patients--the majority--who currently have few effective treatment options. hase 2 clinical trial led by Ludwig Harvard's Stephen Hodi
and Ludwig Memorial Sloan Kettering (MSK)' s Jedd Wolchok has found that the combination of two immunotherapies for first-line treatment of advanced melanoma induces better responses
the combination was effective in the portion of melanoma patients--the majority--who currently have few effective treatment options.
who is also director of the Melanoma Center at the Dana-Farber Cancer Institute.""It's very encouraging to see that pattern reflected in this trial with previously untreated patients."
and is also the Chief of the Melanoma and Immunotherapeutics Service at MSK, found that the same concurrent combination of therapies generated notably positive responses in previously treated patients."
"It was apparent following that trial that the combination should be tested as a first line therapy for metastatic melanoma,
PD-1 is engaged often aberrantly by tumor cells themselves to thwart T cell attack. Both drugs have been approved by the US Food and Drug Administration.
The Phase 2, double-blind trial enrolled 142 patients with advanced melanoma who had received not prior therapy.
The tumors of 109 of these patients had the normal form of the gene BRAF
which is mutated frequently in melanoma. This is significant because while melanoma patients with the mutant BRAF gene can be treated with a targeted therapy, the majority
whose tumors encode a normal BRAF have few effective treatment options. In this group of patients, 72 received ipilimumab plus nivolumab, followed by nivolumab alone,
while 37 got ipilimumab plus placebo. Patients whose tumors had a normal BRAF gene showed an overall objective response rate of 61%.
%This included a 22%complete response rate. Those with a normal BRAF who received only ipilimumab had a response rate of 11%,with no complete responses.
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011